Last Updated: November 8, 2026

Patent: 10,654,924

Summary for Patent: 10,654,924

Title:	IL-17A binding proteins
Abstract:	Binding molecules to IL-17A. The binding molecules are useful in the treatment of disorders, for example psoriasis.
Inventor(s):	Bryan Edwards, Ulla LASHMAR, Brian MCGUINNESS, Mike ROMANOS, Thomas Sandal, Yumin TENG
Assignee:	Crescendo Biologics Ltd
Application Number:	US15/541,889
Patent Claims:	see list of patent claims

Details for Patent 10,654,924

Glossary

Subscribe to access the full database, or Start Trial
Applicant	Tradename	Biologic Ingredient	Dosage Form	BLA	Approval Date	Patent No.	Expiredate
Genentech, Inc.	ACTEMRA	tocilizumab	Injection	125472	October 21, 2013	⤷ Start Trial	2036-01-12
Genentech, Inc.	ACTEMRA	tocilizumab	Injection	125472	November 19, 2018	⤷ Start Trial	2036-01-12
Merck Sharp & Dohme Llc	ZINPLAVA	bezlotoxumab	Injection	761046	October 21, 2016	⤷ Start Trial	2036-01-12
>Applicant	>Tradename	>Biologic Ingredient	>Dosage Form	>BLA	>Approval Date	>Patent No.	>Expiredate

International Patent Family for US Patent 10,654,924

Subscribe to access the full database, or Start Trial
Country	Patent Number	Estimated Expiration
China	107108730	⤷ Start Trial
China	114057873	⤷ Start Trial
European Patent Office	3247724	⤷ Start Trial
European Patent Office	4556491	⤷ Start Trial
Spain	3023709	⤷ Start Trial
>Country	>Patent Number	>Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. We do not provide individual investment advice. This service is not registered with any financial regulatory agency. The information we publish is educational only and based on our opinions plus our models. By using DrugPatentWatch you acknowledge that we do not provide personalized recommendations or advice. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.